Clinic
Children's Health System of Texas
Children's Health System of Texas was paid $65.83M by Medicaid between Dec 2019 and Dec 2024, across 115 billing codes. Its largest line is 99283, emergency room visit (moderate) — 34% of everything it billed.
33Billing provider infoCHILDREN'S HEALTH SYSTEM OF TEXAS
PLANO, TX 75024
PLANO, TX 75024
33aNPI1720480627assigned 09/23/2014
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$65.83M
24GClaims218,219
24DCodes billed115
24AFirst – last monthDec 2019 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#6 of 320
Median peer was paid$205K
This provider vs. median321×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 95 | $25K | |
| 2020 | 7,266 | $1.50M | |
| 2021 | 52,754 | $16.40M | |
| 2022 | 66,333 | $17.28M | |
| 2023 | 57,005 | $18.44M | |
| 2024incomplete | 34,766 | $12.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 34% | 49,022 | 48,190 | $22.69M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 13,270 | 13,047 | $11.96M |
| 95782 | 9.9% | 1,809 | 1,776 | $6.50M | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 8.9% | 2,336 | 2,296 | $5.83M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.5% | 16,270 | 16,051 | $4.26M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 2.6% | 543 | 541 | $1.71M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 2.4% | 1,076 | 1,065 | $1.58M |
| 41899 | Unlisted procedure, dentoalveolar structures | 1.9% | 898 | 882 | $1.22M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1.9% | 23,164 | 22,849 | $1.22M |
| 67311 | 1.7% | 418 | 404 | $1.13M | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.7% | 1,378 | 1,334 | $1.13M |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,275 | 4,221 | $648K |
103 more codes
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 7,692 | $455K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,177 | $396K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,207 | $355K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,429 | $308K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,082 | $293K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 3,668 | $271K |
| 80053 | Comprehensive metabolic panel | <1% | 3,930 | $265K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 4,304 | $260K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 349 | $232K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,469 | $224K |
| 87428 | <1% | 2,880 | $219K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,363 | $218K |
| 87070 | <1% | 3,425 | $208K | |
| 74018 | <1% | 1,056 | $143K | |
| 97803 | <1% | 2,147 | $141K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,924 | $130K |
| 95811 | <1% | 41 | $129K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 434 | $99K |
| 97802 | <1% | 829 | $94K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,551 | $85K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,736 | $82K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,383 | $82K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 25 | $74K |
| 95812 | <1% | 64 | $65K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 768 | $63K |
| 85027 | <1% | 1,384 | $63K | |
| 86140 | <1% | 1,903 | $55K | |
| 87040 | <1% | 779 | $55K | |
| 71045 | Radiologic examination, chest; single view | <1% | 287 | $52K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,003 | $50K |
| 74019 | <1% | 243 | $48K | |
| 81001 | <1% | 1,662 | $48K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,244 | $44K |
| 96156 | <1% | 173 | $40K | |
| 81003 | <1% | 2,146 | $40K | |
| 84439 | <1% | 1,026 | $40K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,811 | $39K |
| 82948 | <1% | 1,271 | $34K | |
| 92567 | <1% | 390 | $33K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 65 | $31K |
| 54161 | <1% | 12 | $28K | |
| 92579 | <1% | 119 | $26K | |
| 96167 | <1% | 146 | $23K | |
| L8613 | Ossicula implant | <1% | 893 | $21K |
| 86003 | <1% | 323 | $21K | |
| 80069 | <1% | 140 | $21K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 262 | $20K |
| 85007 | <1% | 1,248 | $19K | |
| 69210 | <1% | 171 | $18K | |
| 83690 | <1% | 225 | $14K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,219 | $14K |
| 87631 | <1% | 58 | $12K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 205 | $10K |
| 80050 | General health panel | <1% | 55 | $9K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 103 | $9K |
| 70486 | <1% | 15 | $9K | |
| 82784 | <1% | 108 | $9K | |
| 85652 | <1% | 263 | $7K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 12 | $7K |
| 76770 | <1% | 25 | $7K | |
| 84145 | <1% | 196 | $7K | |
| 92552 | <1% | 57 | $5K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 161 | $5K |
| 83516 | <1% | 66 | $4K | |
| 81025 | <1% | 81 | $4K | |
| 92557 | <1% | 17 | $4K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 46 | $4K |
| 83001 | <1% | 49 | $3K | |
| 82728 | <1% | 73 | $3K | |
| 85045 | <1% | 89 | $3K | |
| 82627 | <1% | 34 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,060 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 25 | $3K |
| 86480 | <1% | 43 | $2K | |
| 92587 | <1% | 14 | $2K | |
| 83002 | <1% | 34 | $2K | |
| 83498 | <1% | 12 | $2K | |
| 92556 | <1% | 28 | $2K | |
| 92555 | <1% | 42 | $2K | |
| 82977 | <1% | 27 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 31 | $2K |
| 82610 | <1% | 28 | $1K | |
| 84146 | <1% | 15 | $1K | |
| 86803 | <1% | 57 | $1K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 39 | $1K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,239 | $992.53 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 34 | $961.79 |
| 82040 | <1% | 15 | $821.39 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 12 | $764.98 |
| 83540 | <1% | 13 | $763.18 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 199 | $731.38 |
| 84460 | <1% | 13 | $706.43 | |
| 92551 | <1% | 12 | $645.68 | |
| 82043 | <1% | 12 | $538.44 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 28 | $440.52 |
| 86592 | <1% | 93 | $419.96 | |
| 83735 | <1% | 13 | $296.34 | |
| 0099U | <1% | 61 | $241.27 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 15 | $175.56 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 12 | $107.13 |
| 90670 | 0% | 150 | $0.00 | |
| 90686 | 0% | 1,478 | $0.00 | |
| 90656 | 0% | 115 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFRIES, ROBERT (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Children's Health System of Texas | Dallas, TX | $263.77M |
| Children's Health System of Texas | Dallas, TX | $1.51M |
| Pediatric Imaging Associates LLC | Plano, TX | $1.21M |
| Children's Health System of Texas | Dallas, TX | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.